Oruka Therapeutics (HQ1.STU) Q2 2026 Earnings

13MayConfirmed
Q2 2026
-0.47
-0.45
-0.43
-0.41

Details

Expected EPS
-0.4667381144
Actual EPS
-0.409632
Surprise EPS
0.06
Surprise Percent
+12.24%

Description

Oruka Therapeutics (HQ1.STU) has reported earnings of -0.409632 per share for Q2 2026.

0 Comments

Share your thoughts